Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Clarity Pharmaceuticals Ltd ASX:CU6 |
1,14 B | 0,00% | 0/5 | 0,00% | 0,00% | 144,26% | DOWN |
|
Probiotec ASX:PBP |
0,24 B | 18,25% | 3/4 | 15,18% | -5,54% | 0,00% | UP |
|
Mayne Pharma Group ASX:MYX |
0,19 B | -1,60% | 2/6 | -0,45% | 36,84% | 148,92% | DOWN |
|
Nyrada ASX:NYR |
0,15 B | 0,00% | 0/0 | 0,00% | 0,00% | -37,29% | UP |
|
Bioxyne ASX:BXN |
0,14 B | 0,00% | 0/0 | 0,00% | 0,00% | -100,00% | UP |
|
Vita Life Sciences ASX:VLS |
0,14 B | 3,57% | 2/4 | 0,00% | -384,62% | -100,00% | UP |
|
Recce Pharmaceuticals Ltd ASX:RCE |
0,13 B | 10,43% | 0/0 | 12,35% | -69,77% | 421,74% | DOWN |
|
Kazia Therapeutics NasdaqCM:KZIA |
0,11 B | 224,45% | 4/5 | -97,07% | 71,32% | 95,84% | UP |
|
Island Pharmaceuticals ASX:ILA |
0,11 B | 0,00% | 0/0 | 0,00% | 0,00% | 162,16% | UP |
|
Radiopharm Theranostics ASX:RAD |
0,07 B | 0,00% | 1/2 | -100,00% | 8,45% | 400,00% | DOWN |
|
Neurizon Therapeutics ASX:NUZ |
0,06 B | 0,00% | 0/0 | 0,00% | 0,00% | 211,11% | DOWN |
|
Syntara ASX:SNT |
0,05 B | -63,66% | 3/5 | 0,00% | -42184,52% | 333,33% | DOWN |
|
Incannex Healthcare NasdaqCM:IXHL |
0,04 B | 482,68% | 2/2 | 0,00% | 0,00% | -100,00% | DOWN |
|
Medical Developments International ASX:MVP |
0,05 B | -0,76% | 2/5 | 9,60% | 64,17% | 392,68% | DOWN |
|
Emyria ASX:EMD |
0,04 B | 0,00% | 0/0 | 0,00% | -1674,80% | -100,00% | DOWN |
|
Avecho Biotechnology ASX:AVE |
0,03 B | 0,00% | 3/4 | 0,00% | -173,41% | -100,00% | UP |
|
Little Green Pharma Ltd ASX:LGP |
0,03 B | 391,57% | 1/2 | -17,17% | -13,24% | 80,00% | DOWN |
|
Star Combo Pharma ASX:S66 |
0,03 B | 0,00% | 0/0 | 0,00% | 0,00% | -100,00% | DOWN |
|
Argenica Therapeutics ASX:AGN |
0,02 B | 0,00% | 0/0 | 0,00% | 0,00% | -100,00% | DOWN |
|
Peak Processing ASX:PKP |
0,02 B | 0,00% | 0/0 | 0,00% | 14,08% | -100,00% | DOWN |
